Pharma and Biotech
| Interim CEO: | Rachel Parsonage |
| Interim Chairman: | Alyson Margaret Levett |
| Non-Executive Dir: |
| Address: | The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF |
| Phone: | +44 191 495 7325 |
| Website: | http://www.skinbiotherapeutics.com/ |
| Sector: | Pharma and Biotech(LSE) |
| ISIN: | GB00BF33H870 |
| Currency | UK Pounds |
| Share Price | 9.50p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 10.00p |
| 52 Week Low | 9.00p |
| Volume | 281,058 |
| Shares Issued | 259.04m |
| Market Cap | £24.61m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:30 | 10,000 @ 9.28p |
| 14:16 | 10,000 @ 9.30p |
| 14:08 | 50,000 @ 9.50p |
| 13:24 | 250 @ 9.00p |
| 13:24 | 17 @ 9.00p |
You are here: research